SCHEMBL1487704

SCHEMBL1487704

C=CCC(=O)CC(=O)/C=C/C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.31
TSHR P16473 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1487705 1.00 ALDH1A1 (0.31) ALDH1A1TSHRLMNA
SCHEMBL18741301 0.81
SCHEMBL2911754 0.81
SCHEMBL1487695 0.78 NFE2L2 (0.35) ALDH1A1TSHR
SCHEMBL1487696 0.78 NFE2L2 (0.35) ALDH1A1TSHR
SCHEMBL11973891 0.75 ALDH1A1 (0.35) ALDH1A1TSHRLMNA
SCHEMBL6916408 0.73 LDHA (0.36) TSHR
SCHEMBL8356295 0.73 KDM4E (0.39)
SCHEMBL8966176 0.72
SCHEMBL15499092 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110064712-A1 Dietary Supplement Compositions and Methods of Making and Using the Same AMATO DANIEL MOSES 2011-03-17 US claimed
US-20110064712-A1 Dietary Supplement Compositions and Methods of Making and Using the Same AMATO DANIEL MOSES 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110064712-A1 Dietary Supplement Compositions and Methods of Making and Using the Same SLC5A6, PNLIP, LIPC ALDH1A1 1959/4885TSHR 4782/4885LMNA 1818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.